Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods

Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods

Quinazoline derivatives are potent inhibitors of human epidermal growth factor receptor (EGFR) as anticancer agents. In this study, the cytotoxic effects of a new series of synthesized quinazoline derivatives were evaluated using MTT assay against MCF-7 and HT-29 cell lines. Using molecular docking,...

Full description

Bibliographic Details
Main Authors:	Rezvan Rezaee Nasab, Mahboubeh Mansourian, Farshid Hassanzadeh, Mohsen Shahlaei
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Research in Pharmaceutical Sciences
Subjects:	4-anilinoquinazoline; egfr; molecular docking; molecular dynamics simulation; 4(3h)-quinazolinones
Online Access:	http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=6;spage=509;epage=522;aulast=Nasab

Similar Items

Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives
by: Rezvan Rezaee Nasab, et al.
Published: (2017-01-01)

Structure based design and anti-breast cancer evaluation of some novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor inhibitors
by: Zahra Haghighijoo, et al.
Published: (2018-01-01)

Molecular Docking of Some Quinazolinone Analogues as an EGFR Inhibitors
by: Mahdi Rafieyanbroujeni, et al.
Published: (2021-08-01)

Synthesis, anticancer and apoptosis-inducing activities of quinazoline–isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies
by: Adel S. El-Azab, et al.
Published: (2017-01-01)

Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
by: Cheng W, et al.
Published: (2019-08-01)

6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents
by: Fatemeh Azmian Moghadam, et al.
Published: (2021-06-01)

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
by: Yi Le, et al.
Published: (2020-01-01)

A rapid and convenient method for synthesis of anilinoquinazoline: an improved synthesis of erlotinib derivatives
by: Zahra Haghighijoo, et al.
Published: (2015-09-01)

Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers
by: Mostafa M. Ghorab, et al.
Published: (2021-01-01)

Synthesis and In Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase
by: Malose Jack Mphahlele, et al.
Published: (2017-11-01)

Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives
by: Rezvan Rezaee Nasab, et al.
Published: (2018-01-01)

Synthesis, Anti-microbial and Molecular Docking Studies of Quinazolin-4(3H)-one Derivatives
by: Yahia Nasser Mabkhot, et al.
Published: (2014-06-01)

Design of New Quinazoline Derivative as EGFR (Epidermal Growth Factor Receptor) Inhibitor through Molecular Docking and Dynamics Simulation
by: Herlina Rasyid, et al.
Published: (2020-12-01)

Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors
by: Adel S. El-Azab, et al.
Published: (2020-01-01)

Benzofuran–appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies
by: Malose J. Mphahlele, et al.
Published: (2018-01-01)

Quinazolin-4-one derivatives lacking toxicity-producing attributes as glucokinase activators: design, synthesis, molecular docking, and in-silico ADMET prediction
by: Saurabh C. Khadse, et al.
Published: (2019-12-01)

Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation
by: Malose J. Mphahlele, et al.
Published: (2018-08-01)

Synthesis, characterization, molecular docking studies and biological evaluation of some novel hybrids based on quinazolinone, benzofuran and imidazolium moieties as potential cytotoxic and antimicrobial agents
by: Parvin Asadi, et al.
Published: (2017-09-01)

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
by: Mohamed Alswah, et al.
Published: (2017-12-01)

Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents
by: Safoora Poorirani, et al.
Published: (2018-01-01)

Synthesis, characterization, cytotoxic screening, and density functional theory studies of new derivatives of quinazolin-4(3H)-one Schiff bases
by: Rezvan Rezaee Nasab, et al.
Published: (2017-01-01)

Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking
by: Ya Wang, et al.
Published: (2021-07-01)

S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
by: Adel S. El-Azab, et al.
Published: (2020-01-01)

1,3,4-Thiadiazoline−coumarin hybrid compounds containing D-glucose/D-galactose moieties: Synthesis and evaluation of their antiproliferative activity
by: Vu Ngoc Toan, et al.
Published: (2021-04-01)

Synthesis and In Vitro Cytotoxic Properties of Polycarbo-Substituted 4-(Arylamino)quinazolines
by: Hugues Kamdem Paumo, et al.
Published: (2016-10-01)

Synthesis and cytotoxic evaluation of some quinazolinone- 5-(4-chlorophenyl) 1, 3, 4-oxadiazole conjugates
by: Farshid Hassanzadeh, et al.
Published: (2019-01-01)

Quantum mechanical/molecular mechanical and docking study of the novel analogues based on hybridization of common pharmacophores as potential anti-breast cancer agents
by: Parvin Asadi, et al.
Published: (2017-01-01)

Synthesis and cytotoxic evaluation of some derivatives of triazole-quinazolinone hybrids
by: Farshid Hassanzadeh, et al.
Published: (2019-01-01)

Quinazolinones as Competitive Inhibitors of Carbonic Anhydrase-II (Human and Bovine): Synthesis, in-vitro, in-silico, Selectivity, and Kinetics Studies
by: Ajmal Khan, et al.
Published: (2020-12-01)

Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition
by: Ahmed A. Noser, et al.
Published: (2020-10-01)

Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities
by: Elham Jafari, et al.
Published: (2016-01-01)

Synthesis, molecular docking and biological potentials of new 2-(4-(2-chloroacetyl) piperazin-1-yl)-N-(2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl)acetamide derivatives
by: Shinky Mehta, et al.
Published: (2019-09-01)

NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives
by: Ghorab MM, et al.
Published: (2016-08-01)

Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3
by: Elham Taherian, et al.
Published: (2019-01-01)

Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-<i>b</i>]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors
by: Xinshan Deng, et al.
Published: (2019-02-01)

<i>In silico</i> Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity
by: Shana V. Stoddard, et al.
Published: (2019-12-01)

Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2
by: Frangky Sangande, et al.
Published: (2020-10-01)

In silico and in vitro studies of lupeol and iso-orientin as potential antidiabetic agents in a rat model
by: Malik A, et al.
Published: (2019-05-01)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
by: Leila Emami, et al.
Published: (2021-01-01)

Cytotoxic Evaluation of Some Fused Pyridazino- and Pyrrolo-quinazolinones Derivatives on Melanoma and Prostate Cell Lines
by: Golnaz Vaseghi, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_q9pdd67gai9b4rfi04vvpskkem